Martin Votava, MD, PhD, Prof. Assoc.
Chief Medical Officer, Managing Director
Martin is an expert in pharmacology and regulatory science. He represented the Czech Republic in The Committee for Medicinal Products for Human Use at EMA (2007-2010), while working as the Head of the Preclinical and Clinical Documentation Assessment Unit at the State Institute for Drug Control. He coordinated and provided assessment for centralized marketing authorization procedures and referrals as a rapporteur or a co-rapporteur for new active substances, biosimilar and generic medicinal products. He obtained his education in pharmacology at Charles University in Prague (MD, PhD, Prof. Assoc.), where he held the position as Head of the Pharmacology Department at the 2nd Faculty of Medicine. Martin co-founded PHARMINVENT in 2010 and he currently holds the postion of Chief Medical Officer at PRIMEVIGILANCE.